Oguzhan Atay Sells 24,999 Shares of Billiontoone (NASDAQ:BLLN) Stock

Billiontoone, Inc. (NASDAQ:BLLN) CEO Oguzhan Atay sold 24,999 shares of the firm’s stock in a transaction on Monday, September 14th. The stock was sold at an average price of $100.32, for a total transaction of $2,507,899.68. Following the transaction, the chief executive officer directly owned 16,666 shares of the company’s stock, valued at approximately $1,671,933.12. This represents a 60.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Oguzhan Atay also recently made the following trade(s):

• On Monday, September 14th, Oguzhan Atay sold 5,332 shares of Billiontoone stock. The shares were sold at an average price of $98.00, for a total transaction of $522,536.00.
• On Monday, August 3rd, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The stock was sold at an average price of $137.37, for a total transaction of $1,717,125.00.
• On Monday, August 3rd, Oguzhan Atay sold 32,500 shares of Billiontoone stock. The stock was sold at an average price of $136.95, for a total transaction of $4,450,875.00.
• On Thursday, July 9th, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The stock was sold at an average price of $126.10, for a total value of $1,576,250.00.
• On Monday, July 6th, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The shares were sold at an average price of $122.05, for a total value of $1,525,625.00.
• On Monday, July 6th, Oguzhan Atay sold 26,250 shares of Billiontoone stock. The shares were sold at an average price of $122.05, for a total value of $3,203,812.50.

Billiontoone Stock Performance

NASDAQ:BLLN traded down $0.66 during trading hours on Wednesday, reaching $103.61. 398,500 shares of the stock were exchanged, compared to its average volume of 540,867. The stock has a market capitalization of $4.89 billion and a P/E ratio of 148.01. The firm has a 50 day simple moving average of $110.91 and a 200-day simple moving average of $96.44. The company has a quick ratio of 11.31, a current ratio of 11.69 and a debt-to-equity ratio of 0.17. Billiontoone, Inc. has a 52 week low of $61.96 and a 52 week high of $150.44.

Billiontoone (NASDAQ:BLLN) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.15. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%.The business had revenue of $109.45 million for the quarter. As a group, sell-side analysts forecast that Billiontoone, Inc. will post 0.83 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on BLLN shares. Guggenheim started coverage on shares of Billiontoone in a research report on Monday, June 29th. They issued a “buy” rating and a $125.00 price target on the stock. Weiss Ratings raised shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. JPMorgan Chase & Co. dropped their price objective on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a research note on Thursday, August 6th. Zacks Research cut shares of Billiontoone from a “hold” rating to a “strong sell” rating in a report on Monday, August 31st. Finally, BTIG Research decreased their target price on Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a research note on Thursday, August 6th. Seven research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $125.88.

Hedge Funds Weigh In On Billiontoone

Several hedge funds and other institutional investors have recently modified their holdings of the company. Adams Street Partners LLC acquired a new stake in shares of Billiontoone in the 4th quarter worth about $140,063,000. Wasatch Advisors LP grew its position in Billiontoone by 40.2% in the 2nd quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock worth $62,160,000 after purchasing an additional 148,446 shares during the last quarter. Emerald Advisers LLC grew its position in Billiontoone by 26.8% in the 1st quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock worth $18,911,000 after purchasing an additional 50,613 shares during the last quarter. Capital International Investors acquired a new stake in shares of Billiontoone in the fourth quarter valued at approximately $14,568,000. Finally, Emerald Mutual Fund Advisers Trust raised its holdings in shares of Billiontoone by 11.9% during the first quarter. Emerald Mutual Fund Advisers Trust now owns 132,206 shares of the company’s stock valued at $10,436,000 after buying an additional 14,072 shares during the last quarter.

About Billiontoone

BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company’s technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.

The company’s primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.